First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine

43Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the first multidrug-resistant Proteus mirabilis strain producing the carbapenemase OXA-48 (Pm-OXA-48) isolated at Al-Shifa hospital in Gaza, Palestine. Draft genome sequencing of Pm-OXA-48 identified 16 antimicrobial resistance genes, encoding resistance to β-lactams, aminoglycosides, fluoroquinolones, phenicols, streptothricin, tetracycline, and trimethoprim-sulfamethoxazole. Complete sequencing of the blaOXA-48-harboring plasmid revealed that it is a 72 kb long IncL/M plasmid, harboring carbapenemase gene blaOXA-48, extended spectrum β-lactamase gene blaCTX-M-14, and aminoglycoside resistance genes strA, strB, and aph(3′)-VIb.

Cite

CITATION STYLE

APA

Chen, L., Al Laham, N., Chavda, K. D., Mediavilla, J. R., Jacobs, M. R., Bonomo, R. A., & Kreiswirth, B. N. (2015). First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine. Antimicrobial Agents and Chemotherapy, 59(7), 4305–4307. https://doi.org/10.1128/AAC.00565-15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free